Versant Ventures VII GP, L.P.

10% OwnerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Aug 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.4M
Net Open-Market Flow
-$7.4M
Transactions
12
12 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2025Sell(S)22K$38.97$844K903K
Aug 26, 2025Sell(S)44K$38.97$1.7M1.3M
Aug 26, 2025Sell(S)2K$39.50$67K901K
Aug 26, 2025Sell(S)3K$39.50$137K1.3M
Aug 25, 2025Sell(S)50K$39.53$2.0M1.3M
Aug 25, 2025Sell(S)25K$39.53$979K925K
Aug 25, 2025Sell(S)2K$39.92$86K1.3M
Aug 25, 2025Sell(S)1K$39.92$42K924K
Aug 22, 2025Sell(S)10K$40.03$403K953K
Aug 22, 2025Sell(S)20K$40.03$820K1.4M
Aug 22, 2025Sell(S)6K$40.59$230K1.4M
Aug 22, 2025Sell(S)3K$40.59$114K950K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-111529) within minutes of acceptance. Every field above traces to the original document. Verify it directly: